The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

Belgique Nouvelles Nouvelles

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 56 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 71%

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning MachineLearning MassSpectrometry Spectrometry Tuberculosis SSRN TheLancet

By Dr. Chinta SidharthanFeb 28 2023Reviewed by Aimee Molineux *Important notice: Preprints with The Lancet / SSRN publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Current tuberculosis detection methods include immunological exams, detecting the etiological agent from sputum smears, and molecular biology methods. While sputum smear tests are fast, their specificity and sensitivity in detecting tuberculosis are low, whereas mycobacterial cultures, which are accurate, require longer processing times and are difficult for large-scale, same-day testing of tuberculosis patients in general hospitals.

Serum samples were collected for NPELDI MS analysis to determine metabolic fingerprints, which were processed using machine learning algorithms to identify biomarkers for drug-sensitive and drug-resistant tuberculosis. The biomarkers used to differentiate between rifampicin-sensitive and rifampicin-resistant tuberculosis patients included uric acid, taurine, ascorbic acid, and homocysteine, which were elevated in rifampicin-resistant tuberculosis patients. The researchers believe that sulfur amino acids such as homocysteine and taurine may indicate drug-resistant tuberculosis as they are associated with antioxidant and membrane-stabilizing activity.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

New study finds forgoing one food may treat eosinophilic esophagitis as well as excluding sixNew study finds forgoing one food may treat eosinophilic esophagitis as well as excluding sixEliminating animal milk alone from the diet of adults with eosinophilic esophagitis (EoE) is as effective at treating the disease as eliminating animal milk plus five other common foods, a new clinical trial has found. For people with EoE whose disease remains active after they forgo animal milk, a more restrictive diet may help them achieve remission, according to the researchers. These findings were published today in the journal The Lancet Gastroenterology & Hepatology.
Lire la suite »

New email scam warning for people using mobile or telephone bankingCyber criminals could empty your bank account and harvest your personal details in new email scam
Lire la suite »

Mum transforms small bathroom using £2 B&M and charity shop bargainsMum transforms small bathroom using £2 B&M and charity shop bargainsThe savvy Stockport shopper managed to revamp the room for under £50
Lire la suite »

Using sweat to diagnosis disease: soft microfluidic analysis systems assess health statusUsing sweat to diagnosis disease: soft microfluidic analysis systems assess health statusUsing sweat to diagnosis disease: soft microfluidic analysis systems assess health status NorthwesternU ScienceMagazine sweat diagnosis disease health
Lire la suite »

Research team delivers a new first in heart failure treatment using cell therapyResearch team delivers a new first in heart failure treatment using cell therapyPhysician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by improving the heart's pumping ability, as measured by ejection fraction, and reducing the risk of heart attack or stroke, especially in patients who have high levels of inflammation. Also, a strong signal was found in the reduction of cardiovascular death in patients treated with cells. The findings are published in the Journal of the American College of Cardiology.
Lire la suite »



Render Time: 2025-03-06 17:11:06